Sponsor Pipeline

Suzhou Junjing BioSciences Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06909136 A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined… Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly Active, Not Recruiting
NCT06940401 JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations NSCLC Active, Not Recruiting
Disease Areas
Myelofibrosis (1) Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Suzhou Junjing BioSciences Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free